These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 17481713)

  • 1. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
    Williams AN; Simon RA; Woessner KM; Stevenson DD
    J Allergy Clin Immunol; 2007 Aug; 120(2):273-7. PubMed ID: 17481713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.
    Dursun AB; Woessner KA; Simon RA; Karasoy D; Stevenson DD
    Ann Allergy Asthma Immunol; 2008 May; 100(5):420-5. PubMed ID: 18517072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
    Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
    J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease.
    Hope AP; Woessner KA; Simon RA; Stevenson DD
    J Allergy Clin Immunol; 2009 Feb; 123(2):406-10. PubMed ID: 19056109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD; Simon RA
    Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
    Fraj J; Valero A; Vives R; Pérez I; Borja J; Izquierdo I; Picado C
    Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of celecoxib in patients with aspirin-sensitive asthma.
    Woessner KM; Simon RA; Stevenson DD
    Arthritis Rheum; 2002 Aug; 46(8):2201-6. PubMed ID: 12209526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma.
    Mascia K; Haselkorn T; Deniz YM; Miller DP; Bleecker ER; Borish L;
    J Allergy Clin Immunol; 2005 Nov; 116(5):970-5. PubMed ID: 16275362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.
    Lee RU; White AA; Ding D; Dursun AB; Woessner KM; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):130-5. PubMed ID: 20674823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma.
    Stevenson DD; Simon RA
    J Allergy Clin Immunol; 2001 Jul; 108(1):47-51. PubMed ID: 11447381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day].
    Gosepath J; Schäfer D; Mann WJ
    Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of parecoxib in asthmatic patients with aspirin-exacerbated respiratory disease.
    Valero A; Sánchez-López J; Bartra J; Serrano C; Muñoz-Cano R; Roca J; Picado C
    Int Arch Allergy Immunol; 2011; 156(2):221-3. PubMed ID: 21597303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in an oral aspirin challenge protocol for the diagnosis of aspirin hypersensitivity.
    Cormican LJ; Farooque S; Altmann DR; Lee TH
    Clin Exp Allergy; 2005 Jun; 35(6):717-22. PubMed ID: 15969660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity.
    Knowles SR; Drucker AM; Weber EA; Shear NH
    Ann Pharmacother; 2007 Jul; 41(7):1191-200. PubMed ID: 17609236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma outcomes after endoscopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients.
    Awad OG; Fasano MB; Lee JH; Graham SM
    Am J Rhinol; 2008; 22(2):197-203. PubMed ID: 18416980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics.
    Stevenson DD; Simon RA; Mathison DA; Christiansen SC
    Ann Allergy Asthma Immunol; 2000 Dec; 85(6 Pt 1):477-82. PubMed ID: 11152169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
    Mastalerz L; Sanak M; Gawlewicz-Mroczka A; Gielicz A; Cmiel A; Szczeklik A
    Thorax; 2008 Jan; 63(1):27-34. PubMed ID: 17584993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema.
    Wong JT; Nagy CS; Krinzman SJ; Maclean JA; Bloch KJ
    J Allergy Clin Immunol; 2000 May; 105(5):997-1001. PubMed ID: 10808182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.